|
Statement of Cash Flows (USD $)
In Thousands, unless otherwise specified
|
3 Months Ended |
|
May 04, 2013
|
Apr. 28, 2012
|
| Operating activities: |
|
|
| Net income (loss) |
$ 1,570 |
$ (1,157) |
| Adjustments to reconcile net income (loss) to net cash used in operating activities: |
|
|
| Depreciation and amortization |
2,933 |
2,107 |
| Amortization of deferred financing costs |
78 |
7 |
| Warrant expense related to professional service providers for services rendered |
0 |
43 |
| Stock-based compensation expense |
2,359 |
6,330 |
| Deferred income tax (benefit) expense |
(265) |
4,354 |
| Changes in operating assets and liabilities: |
|
|
| Prepaid income taxes |
(585) |
0 |
| Income tax receivable |
0 |
(7,400) |
| Inventories |
(14,508) |
(12,741) |
| Prepaid expenses and other assets |
941 |
(3,621) |
| Accounts payable |
703 |
(799) |
| Income taxes payable |
(6,525) |
(8,120) |
| Accrued salaries and wages |
(1,479) |
(7,818) |
| Deferred rent |
2,405 |
1,555 |
| Other accrued expenses |
602 |
3,562 |
| Net cash used in operating activities |
(11,771) |
(23,698) |
| Investing activities: |
|
|
| Capital expenditures |
(8,148) |
(4,801) |
| Net cash used in investing activities |
(8,148) |
(4,801) |
| Financing activities: |
|
|
| Proceeds from exercise of warrants and stock options to purchase common stock |
158 |
201 |
| Repurchase of unvested restricted shares related to stock option exercises |
0 |
(17) |
| Excess tax benefit related to restricted shares and the exercise of stock options |
402 |
1,525 |
| Net cash provided by financing activities |
560 |
1,709 |
| Net decrease in cash and cash equivalents |
(19,359) |
(26,790) |
| Cash and cash equivalents at beginning of period |
56,081 |
41,293 |
| Cash and cash equivalents at end of period |
$ 36,722 |
$ 14,503 |